1. Home
  2. PGEN vs PSNY Comparison

PGEN vs PSNY Comparison

Compare PGEN & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Polestar Automotive Holding UK PLC ADS

PSNY

Polestar Automotive Holding UK PLC ADS

HOLD

Current Price

$19.09

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
PSNY
Founded
1998
2017
Country
United States
Sweden
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
PGEN
PSNY
Price
$4.12
$19.09
Analyst Decision
Buy
Sell
Analyst Count
5
2
Target Price
$8.33
$15.00
AVG Volume (30 Days)
2.8M
75.4K
Earning Date
05-13-2026
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$230,981,000.00
N/A
Revenue This Year
$1,115.92
$31.06
Revenue Next Year
$81.04
$47.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.23
$0.50
52 Week High
$5.47
$23.28

Technical Indicators

Market Signals
Indicator
PGEN
PSNY
Relative Strength Index (RSI) 54.94 53.99
Support Level $3.91 $15.55
Resistance Level $4.31 $22.75
Average True Range (ATR) 0.19 1.16
MACD 0.00 -0.09
Stochastic Oscillator 64.01 41.43

Price Performance

Historical Comparison
PGEN
PSNY

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About PSNY Polestar Automotive Holding UK PLC ADS

Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.

Share on Social Networks: